Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease
Yulia K. Komleva, Ilia Potapenko, Olga L. Lopatina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11588-11588
Open Access | Times Cited: 13

Showing 13 citing articles:

NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1775-1789
Open Access | Times Cited: 33
MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease
Abdul Naeem, Ravi Prakash, Neha Kumari, et al.
Brain Behavior and Immunity (2023) Vol. 116, pp. 70-84
Closed Access | Times Cited: 27
Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease
Dhanshree Jha, Erik N.T.P. Bakker, Rahul Kumar
Journal of Neurochemistry (2023)
Open Access | Times Cited: 23
Research progress of NLRP3 inflammasome and its inhibitors with aging diseases
Zhuo Yuan, Dongke Yu, Tingting Gou, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175931-175931
Open Access | Times Cited: 16
Decoding NLRP3 Inflammasome Activation in Alzheimer’s Disease: A Focus on Receptor Dynamics
Ranika Maurya, Abha Sharma, Saba Naqvi
Molecular Neurobiology (2025)
Closed Access
Impact of NLRP3 Depletion on Aging-Related Metaflammation, Cognitive Function, and Social Behavior in Mice
Е. Д. Хилажева, А. I. Mosiagina, Yu. A. Panina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16580-16580
Open Access | Times Cited: 8
Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment
Chujun Deng, Huize Chen, Zeyu Meng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Taylor J. Kelty, Ryan J. Dashek, W. David Arnold, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 01, pp. 077-088
Closed Access | Times Cited: 7
Physiological and Pathological Remodeling of Cerebral Microvessels
П. П. Трегуб, Anton S. Averchuk, Tatyana I. Baranich, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12683-12683
Open Access | Times Cited: 12
Metabolic Plasticity of a Developing and Aging Brain
А. Б. Салмина
Нейрохимия (2023) Vol. 40, Iss. 3, pp. 197-210
Closed Access | Times Cited: 2
A Novel Strategy for Alzheimer’s Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora
Li Huang, Zhaogang Lu, Hexin Zhang, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S227-S239
Open Access | Times Cited: 3
The Role of Metaflammation in the Development of Senescence-Associated Secretory Phenotype and Cognitive Dysfunction in Aging Mice
Е. Д. Хилажева, Оlga S. Belozor, Yu. A. Panina, et al.
Journal of Evolutionary Biochemistry and Physiology (2022) Vol. 58, Iss. 5, pp. 1523-1539
Closed Access | Times Cited: 3
Metabolic Plasticity in Developing and Aging Brain
А. Б. Салмина
Neurochemical Journal (2023) Vol. 17, Iss. 3, pp. 325-337
Closed Access | Times Cited: 1
Page 1

Scroll to top